Kumquat Biosciences

Kumquat Biosciences is a small molecule oncology company backed by Roche and Eli Lilly.

Takeda is offering Kumquat the chance to make $1.2-plus billion in a pact that centers around an unnamed immuno-oncology small-molecule inhibitor.

Gabrielle Masson Apr 16, 2024 11:34am